Human Radiosensitivity and Radiosusceptibility: What Are the Differences?Laura El Nachef, Nicolas Foray, Audrey Bouchet et al.|International Journal of Molecular Sciences|2021Cited by 73
Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1L. Képénékian, P. Combemale, Thomas Mognetti et al.|European Journal of Endocrinology|2016Cited by 69
Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1P. Combemale, Thomas Mognetti, L. Valeyrie‐Allanore et al.|PLoS ONE|2014Cited by 60
The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trialBehrouz Kassaï, Laurence Lion‐François, François Gueyffier et al.|Orphanet Journal of Rare Diseases|2014Cited by 57
Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 PatientsMehdi Brahmi, P. Combemale, Philippe Thiesse et al.|PLoS ONE|2015Cited by 52